Metastatic Burden in Hormone-Naive Prostate Cancer: A Tale of Two Subgroups

被引:1
|
作者
Haran, A. M. [1 ,2 ,3 ,4 ]
Ali, A. [1 ,2 ,3 ]
Clarke, N. W. [1 ,2 ,3 ,4 ]
机构
[1] Univ Manchester, Div Canc Sci, Genitourinary Canc Res Grp, Manchester, Lancs, England
[2] Univ Manchester, Div Canc Sci, FASTMAN Ctr Excellence, Manchester, Lancs, England
[3] Christie NHS Fdn Trust, Dept Surg, Wilmslow Rd, Manchester M20 4BX, Lancs, England
[4] Salford Royal NHS Fdn Trust, Dept Urol, Manchester, Lancs, England
关键词
D O I
10.1016/j.clon.2019.12.003
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:209 / 212
页数:4
相关论文
共 50 条
  • [41] Preliminary efficacy and tolerability of chemohormonal therapy in metastatic hormone-naive prostate cancer: The first real-life experience in Asia
    Poon, Darren M. C.
    Chan, Tim
    Chan, Kuen
    Chan, Michelle
    Lee, Eric K. C.
    Law, Kitty
    Lam, Daisy
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2018, 14 (04) : 347 - 352
  • [42] The preliminary efficacy and tolerability of chemohormonal therapy in metastatic hormone-naive prostate cancer - the first Asia's real life experience
    Poon, D. M.
    Chan, T.
    Chan, K.
    Chan, M.
    Lee, E.
    Law, K.
    Lam, D.
    INTERNATIONAL JOURNAL OF UROLOGY, 2017, 24 : 10 - 11
  • [43] Metabolic Alterations, Aggressive Hormone-Naive Prostate Cancer and Cardiovascular Disease: A Complex Relationship
    Di Francesco, Simona
    Robuffo, Iole
    Caruso, Marika
    Giambuzzi, Giulia
    Ferri, Deborah
    Militello, Andrea
    Toniato, Elena
    MEDICINA-LITHUANIA, 2019, 55 (03):
  • [44] Taxane Chemotherapy for Hormone-naive Prostate Cancer with its expanding Role as Breakthrough Strategy
    Shiota, Masaki
    Yokomizo, Akira
    Eto, Masatoshi
    FRONTIERS IN ONCOLOGY, 2016, 5
  • [45] Upfront docetaxel with androgen deprivation therapy in the elderly patient with metastatic hormone-naive prostate cancer: Single institution experience.
    Rayner, Lindsay Jennifer Andrew
    Challapalli, Amarnath
    Blackmore, Eve
    Rea, Katherine
    Wells, Natasha
    White, Paul
    Hilman, Serena
    Masson, Susan
    Huckett, Rebecca
    Garadi, Krishna
    Kirk, Hannah
    Kabala, Julian
    Oikonomopoulou, Viktoria
    Bahl, Amit
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [46] LONG-TERM RESULTS OF CYTOREDUCTIVE RADICAL PROSTATECTOMY IN MEN WITH HORMONE-NAIVE, LOW VOLUME METASTATIC PROSTATE CANCER(MHNPCA)
    John, Patricia
    Pfister, David
    Heidenreich, Axel
    Hartmann, Florian
    JOURNAL OF UROLOGY, 2020, 203 : E1221 - E1222
  • [47] Fatigue in hormone-naive prostate cancer patients treated with radical prostatectomy or definitive radiotherapy
    Kyrdalen, A. E.
    Dahl, A. A.
    Hernes, E.
    Cvancarova, M.
    Fossa, S. D.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2010, 13 (02) : 144 - 150
  • [48] Validation and development of the CHAARTED criteria in patients with hormone-naive metastatic prostate cancer: A multi-institutional retrospective study in Japan
    Okamoto, Teppei
    Hatakeyama, Shingo
    Narita, Shintaro
    Arai, Yoichi
    Habuchi, Tomonori
    Ohyama, Chikara
    INTERNATIONAL JOURNAL OF UROLOGY, 2020, 27 (01) : 90 - 91
  • [49] Androgen deprivation therapy with chemotherapy or abiraterone for patients with metastatic hormone-naive prostate cancer: a systematic review and meta-analysis
    Sun, Guijiang
    Chen, Xuanrong
    Gong, Xue
    Chen, Yawei
    Li, Guilai
    Wei, Fang
    Jiang, Aili
    Niu, Yuanjie
    Shang, Zhiqun
    FUTURE ONCOLOGY, 2019, 15 (10) : 1167 - 1179
  • [50] Low-molecular-weight protein tyrosine phosphatase expression as a prognostic factor for men with metastatic hormone-naive prostate cancer
    Ohtaka, Mari
    Miyoshi, Yasuhide
    Kawahara, Takashi
    Ohtake, Shinji
    Yasui, Masato
    Uemura, Koichi
    Yoneyama, Shuko
    Hattori, Yusuke
    Teranishi, Jun-ichi
    Yokomizo, Yumiko
    Uemura, Hiroji
    Miyamoto, Hiroshi
    Yao, Masahiro
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2017, 35 (10) : 607.e9 - 607.e14